Lab-on-a-Chip Market Share

Regionally, the global lab-on-a-chip (LOC) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in Asia Pacific industry is predicted to hold largest revenue share by 2036, impelled by growing occurrence of cardiovascular and renal diseases, and rising developments in healthcare infrastructure in the region. More than 20 million people aged 65 years or older in China suffered from kidney damage, and about 14 million from decreased renal function in the year 2019.

Moreover, the market in North America is projected to occupy the largest share during the forecast period ascribing to the escalating investments for drug discovery by pharmaceutical companies in the region. In addition, rapid adoption of advanced medical technologies is also expected to fuel the lab-on-a-chip (LOC) market growth in the region in the coming years.